عنوان

Sandostatin® in the Treatment of Acromegaly :

شابک

3642736947

شابک

9783642736940

شماره

b541558

عنوان اصلي

Sandostatin® in the Treatment of Acromegaly :

نام عام مواد

[Book]

ساير اطلاعات عنواني

Consensus Round Table, Amsterdam 1987

نام نخستين پديدآور

edited by Steven W.J. Lamberts.

محل نشرو پخش و غیره

Berlin, Heidelberg

نام ناشر، پخش کننده و غيره

Springer Berlin Heidelberg

تاریخ نشرو بخش و غیره

1988

نام خاص و کميت اثر

(x, 171 pages 78 illustrations)

متن يادداشت

1. Clinical Aspects of Growth Hormone Hypersecretory States --;2. Correlation Between Preoperative Testing and Tumour Morphology in Acromegaly --;3. Acromegaly: Objectives of Therapy --;4. Surgical Treatment of Acromegaly --;5. External Radiation Therapy of Acromegaly --;6. Bromocriptine Treatment of Acromegaly --;7. Chemical Structure, Pharmacodynamic Profile and Pharmacokinetics of SMS 201-995 (Sandostatin®) --;8. Studies on the Acute and Chronic Effects of Sandostatin® in Acromegaly --;9. Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting Somatostatin --;10. Treatment of Acromegaly with the Somatostatin Analogue SMS 201-995 (Sandostatin®) --;11. Observations During a Clinical Trial of Sandostatin® in Acromegalic Patients --;12. Effects of Long-Term Administration of Sandostatin® (SMS 201-995) at Increasing Doses in 40 Acromegalic Patients. Results from the French Sandostatin Acromegaly Study Group --;13. Experience with Sandostatin® in Various Groups of Acromegalic Patients --;14. Treatment of Acromegaly with SMS 201-995 (Sandostatin®): Clinical, Biochemical and Morphologic Study --;15. Long-Term Treatment of Acromegaly by Continuous Subcutaneous Infusion of the Long-Acting Somatostatin Analog Sandostatin® (SMS 201-995, Octreotide) --;16. Sandostatin® (SMS 201-995) Treatment of Acromegaly: Acute and Chronic Effects --;17. Long-Term Efficacy of Sandostatin® (SMS 201-995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group --;18a. Pulsatile Administration of SMS 201-995 (Sandostatin®) in the Treatment of Acromegaly --;18b. Treatment of Acromegaly with SMS 201-995 (Sandostatin®): A Collaborative Study in Japan --;19. Long-Term Treatment of Resistant Acromegaly with a Somatostatin Analog (SMS 201-995, Sandostatin®) --;20. High-Dose, Long-Term, Continuous Subcutaneous Infusion of SMS 201-995 (Sandostatin®) in Acromegaly --;21. Long-Term Therapy of Acromegaly with SMS 201-995 (Sandostatin®) --;22. Successful Treatment of Ophthalmoplegia in Acromegaly with the Somatostatin Analogue SMS 201-995 (Sandostatin®) --;23. Sandostatin® (SMS 201-995) in the Treatment of Acromegaly --;24. Somatostatin Octapeptide (SMS 201-995, Sandostatin®) in the Medical Treatment of Acromegaly --;25a. SMS 201-995 (Sandostatin®) Treatment of Therapy-Resistant Acromegaly --;25b. Sandostatin® (SMS 201-995) Can Exert a Direct Analgesic Effect --;25c. Relapsing Acromegaly Resistant to Both Bromocriptine and Sandostatin® Treatment --;26. Consensus Discussion and Conclusions.

متن يادداشت

Acromegaly is a relatively rare chronic disease. Since it also has disfiguring properties - especially of the head and face - acromegaly has serious psychological consequences which are reinforced by the awareness of factors such as excessive sweating.

موضوع مستند نشده

Medicine.

موضوع مستند نشده

Neurosciences.

موضوع مستند نشده

Toxicology.

شماره رده

نشانه اثر

مستند نام اشخاص تاييد نشده

edited by Steven W.J. Lamberts.

مستند نام اشخاص تاييد نشده

Steven W J Lamberts

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y